Movado Group Inc (MOV) CFO receives 21543-share stock award

Rhea-AI Filing Summary

DEMARSILIS SALLIE A reported acquisition or exercise transactions in this Form 4 filing.

MOVADO GROUP INC Chief Financial Officer Sallie A. DeMarsilis received a grant of 21543 shares of common stock as compensation. The shares were awarded at no cash cost and increase her directly held position to 129199 shares. This reflects a stock-based award rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DEMARSILIS SALLIE A

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	21,543	$0.00	--

Holdings After Transaction: Common Stock — 129,199 shares (Direct)

Footnotes (1)

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEMARSILIS SALLIE A

(Last) (First) (Middle)

C/O MOVADO GROUP, INC.,

650 FROM ROAD, SUITE 375

(Street)

PARAMUS NEW JERSEY 07652

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOVADO GROUP INC [ MOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/23/2026		A		21,543	A	$0	129,199	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Mitchell C. Sussis, attorney-in-fact	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MOVADO GROUP INC (MOV) report for its CFO?

MOVADO GROUP INC reported a stock grant to its CFO. Sallie A. DeMarsilis received 21543 shares of common stock as a grant or award, increasing her directly held position to 129199 shares, with no cash paid per share in this transaction.

Was the MOVADO GROUP INC CFO transaction a stock purchase or a grant?

The transaction was a stock grant, not a market purchase. It is coded as a grant, award, or other acquisition, with a price per share of 0.0000, indicating compensation-based issuance rather than an open-market buy.

How many MOVADO GROUP INC shares does the CFO hold after this Form 4?

After the award, the CFO holds 129199 common shares directly. The Form 4 shows that the grant of 21543 shares increased Sallie A. DeMarsilis’s directly owned position to this level, with no derivative positions reported in this filing.

Does the MOVADO GROUP INC CFO Form 4 indicate any stock sales?

No stock sales are reported for the CFO in this filing. The Form 4 shows only one transaction, a grant or award acquisition of 21543 common shares, and no dispositions or open-market sales of MOVADO GROUP INC stock.

Is the MOVADO GROUP INC CFO grant a cash transaction affecting company proceeds?

The CFO grant does not involve cash paid per share. The transaction price is listed as 0.0000 per share, indicating a stock-based compensation award rather than a cash-funded purchase that would provide proceeds to the company.